Global cellular responses to β-methyl-amino-L-alanine (BMAA) by olfactory ensheathing glial cells (OEC)

Toxicon : Official Journal of the International Society on Toxinology
Alexander S ChiuBrett A Neilan

Abstract

This study utilised a proteomics approach to identify any differential protein expression in a glial cell line, rat olfactory ensheathing cells (OECs), treated with the cyanotoxin β-methylamino-l-alanine (BMAA). Five proteins of interest were identified, namely Rho GDP-dissociation inhibitor 1 (RhoGDP1), Nck-associated protein 1 (NCKAP1), voltage-dependent anion-selective channel protein 1 (VDAC1), 3-hydroxyacyl-CoA dehydrogenase type-2 (3hCoAdh2), and ubiquilin-4 (UBQLN4). Four of these candidates, nuclear receptor subfamily 4 group A member 1 (Nur77), cyclophilin A (CyPA), RhoGDP1 and VDAC1, have been reported to be involved in cell growth. A microarray identified UBQLN4, palladin and CyPA, which have been implicated to have roles in excitotoxicity. Moreover, the NCKAP1, UBQLN4, CyPA and 3hCoAdh2 genes have been associated with abnormal protein aggregation. Differential expression of genes involved in mitochondrial activity, Nur77, 3hCoAdh2, VDAC1 and UBQLN4, were also identified. Confirmatory reverse transcription quantitative PCR (RT-qPCR) analysis of transcripts generated from the genes of interest corroborated the differential expression trends identified in the global protein analysis. BMAA induced cell cycle arrest in t...Continue Reading

References

Mar 1, 1993·Pharmacology, Biochemistry, and Behavior·Y MatsuokaD Naritoku
Jul 5, 2001·The Journal of Comparative Neurology·S J HwangJ G Valtschanoff
Sep 13, 2001·Molecular Biology of the Cell·M BoukhelifaC A Otey
Apr 12, 2002·The Journal of Biological Chemistry·Vyacheslav YurchenkoMichael Bukrinsky
Jul 4, 2002·Molecular & Cellular Proteomics : MCP·Guoan ChenDavid G Beer
Feb 1, 1953·The Journal of Nervous and Mental Disease·A ARNOLDV S PALLADINO
Nov 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Paul Alan CoxSusan J Murch
Jul 9, 2004·Molecular & Cellular Proteomics : MCP·Qiang TianLeroy E Hood
Sep 10, 2004·Acta Neurologica Scandinavica·S J MurchO W Sacks
Sep 15, 2005·Neurology·Thomas J MontineDouglas Galasko
Dec 8, 2006·Expert Opinion on Therapeutic Targets·Xiao-kun Zhang
Jan 24, 2007·Biological Procedures Online·Jeanine S MoreyFrances M Van Dolah
Jan 15, 2008·Life Sciences·Vardan T Karamyan, Robert C Speth
Mar 4, 2009·Acta Neurologica Scandinavica·J PabloD C Mash
Apr 15, 2009·Neurology·L R SnyderT J Montine
Oct 14, 2009·Toxicon : Official Journal of the International Society on Toxinology·Aifeng LiZhenyu Wang
Dec 16, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Walter G Bradley, Deborah C Mash
Dec 16, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Paul Alan CoxWalter G Bradley
May 5, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sara JonassonBirgitta Bergman
Aug 21, 2010·Genome Génome / Conseil National De Recherches Canada·S VirtueA Vidal-Puig
Dec 7, 2010·Biochimica Et Biophysica Acta·Liora LindenboimReuven Stein
Mar 30, 2011·Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology·Brenda Thornton, Chhandak Basu
Aug 14, 2012·Toxicon : Official Journal of the International Society on Toxinology·Alexander S ChiuBrett A Neilan
Mar 20, 2013·Scientific Reports·Alexander S ChiuBrett A Neilan
Jul 29, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Justin E BekelmanKatrina Armstrong

❮ Previous
Next ❯

Citations

May 4, 2016·Toxicon : Official Journal of the International Society on Toxinology·Matjaž NovakBojana Žegura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Ai zheng = Aizheng = Chinese journal of cancer
Jun-Jie QianZhi-Xian Sun
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Haixia ZhuZhaojun Zeng
© 2021 Meta ULC. All rights reserved